Department of Orthopaedic Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Department of Orthopaedic Surgery, UCLA Comprehensive Spine Center, Santa Monica, California.
Global Spine J. 2012 Dec;2(4):239-48. doi: 10.1055/s-0032-1315454. Epub 2012 Oct 9.
Bone graft substitutes have been used routinely for spine fusion for decades, yet clinical evidence establishing comparative data remains sparse. With recent scrutiny paid to the outcomes, complications, and costs associated with osteobiologics, a need to improve available data guiding efficacious use exists. We review the currently available clinical literature, studying the outcomes of various biologics in posterolateral lumbar spine fusion, and establish the need for a multicenter, independent osteobiologics registry.
几十年来,骨移植替代物已被常规用于脊柱融合,但仍缺乏临床证据来建立对比数据。随着最近对与骨生物材料相关的结果、并发症和成本的关注,需要改进现有的数据来指导其有效使用。我们回顾了目前可用的临床文献,研究了各种生物材料在后外侧腰椎融合中的结果,并确定需要建立一个多中心、独立的骨生物材料登记处。